Chinese ADC, RNA Therapy Developers Lead May/June Fundraising

 
• By Dexter Jie Yan

Emerging companies including Bliss Biopharmaceutical, Coherent Biopharma and WestGene Biopharma lifted China biotech funding from May to mid-June.

funding
Antibody-drug conjugates and RNA therapies come to fore as promising assets in China • Source: Shutterstock

More from China

More from Focus On Asia